Your browser doesn't support javascript.
loading
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study.
Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; Fallara, Giuseppe; Styrke, Johan; Franck Lissbrant, Ingela; Stattin, Pär.
Afiliação
  • Gedeborg R; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Garmo H; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Thellenberg-Karlsson C; Translational Oncology and Urology Research (TOUR), King's College London, Guy's Hospital, London, UK.
  • Fallara G; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Styrke J; Division of Experimental Oncology, Unit of Urology URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Franck Lissbrant I; Vita-Salute San Raffaele University, Milan, Italy.
  • Stattin P; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
Acta Oncol ; 61(3): 328-332, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34979865
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Androstenos Tipo de estudo: Diagnostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Androstenos Tipo de estudo: Diagnostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article